MB, Levis & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.78M | Buy |
11,676
+135
| +1% | +$20.6K | 0.78% | 24 |
|
2025
Q1 | $1.91M | Buy |
11,541
+9
| +0.1% | +$1.49K | 0.89% | 20 |
|
2024
Q4 | $1.67M | Buy |
11,532
+36
| +0.3% | +$5.21K | 0.84% | 22 |
|
2024
Q3 | $1.86M | Buy |
11,496
+8
| +0.1% | +$1.3K | 0.92% | 21 |
|
2024
Q2 | $1.68M | Buy |
11,488
+101
| +0.9% | +$14.8K | 0.88% | 21 |
|
2024
Q1 | $1.8M | Sell |
11,387
-92
| -0.8% | -$14.6K | 0.97% | 21 |
|
2023
Q4 | $1.8M | Buy |
11,479
+45
| +0.4% | +$7.05K | 1.03% | 19 |
|
2023
Q3 | $1.78M | Buy |
11,434
+9
| +0.1% | +$1.4K | 1.15% | 17 |
|
2023
Q2 | $1.89M | Sell |
11,425
-28
| -0.2% | -$4.64K | 1.21% | 17 |
|
2023
Q1 | $1.78M | Buy |
11,453
+235
| +2% | +$36.4K | 1.24% | 17 |
|
2022
Q4 | $1.98M | Buy |
+11,218
| New | +$1.98M | 1.55% | 13 |
|